LoginRegister
    Novartis Zolgensma lottery-style giveaway upsets patient groupsNovartis Zolgensma lottery-style giveaway upsets patient groups
    Indian Pharmacopoeia recognized by AfghanistanIndian Pharmacopoeia recognized by Afghanistan
    Panacea Biotec wins Rs 170 crore Pentavalent vaccine orders from UN agenciesPanacea Biotec wins Rs 170 crore Pentavalent vaccine orders from UN agencies
    Lupin partner Concord gets USFDA nod for generic version of Myfortic tabletsLupin partner Concord gets USFDA nod for generic version of Myfortic tablets
    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; DetailsNPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details
    Sun Pharma arm-SPARC, Bioprojet ink licensing pact for auto-immune diseases drug SCD-044Sun Pharma arm-SPARC, Bioprojet ink licensing pact for auto-immune diseases drug SCD-044
    Merck Ebola vaccine Ervebo gets USFDA okayMerck Ebola vaccine Ervebo gets USFDA okay
    FTC seeks to block Illumina from buying PacBioFTC seeks to block Illumina from buying PacBio
    NPPA show-cause notices to Sun Pharma, Glenmark, Abbott, Lupin for self-exemption from price cap for anti-diabetic drugsNPPA show-cause notices to Sun Pharma, Glenmark, Abbott, Lupin for self-exemption from price cap for...
    Withdraw decision of NPPA increasing ceiling price of essential life-saving drug; CPI writes to PMWithdraw decision of NPPA increasing ceiling price of essential life-saving drug; CPI writes to PM
    Indian pharma sector to grow at 10-12 pc during FY19-22, says ICRAIndian pharma sector to grow at 10-12 pc during FY19-22, says ICRA
    Astellas, Seattle Genetics cancer drug Padcev gets speedy nod from USFDAAstellas, Seattle Genetics cancer drug Padcev gets speedy nod from USFDA
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X